Related Experiment Video
Updated: Aug 5, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Combining Artificial Intelligence and Human Expertise in Pursuit of Novel PolQ Inhibitors
Ageo Miccoli1, Annabelle Charnock1, Alexis Denis2
1Sygnature Discovery Ltd., Alderley Park, Alderley Edge, Cheshire SK10 4TG, U.K.
Abstract:
Application of generative AI, synergistically with traditional knowledge-based approaches, has expedited the discovery of small-molecule PolQ polymerase domain inhibitors. Leveraging AI-generated ligand designs, a structurally diverse set of compounds were synthesized and evaluated, ultimately identifying a novel oxime-based scaffold as a promising starting point. Although the initial hit demonstrated only modest biochemical potency, the oxime moietyan unexplored vector in this chemical spaceoffered an opportunity for strategic substitution. Gratifyingly, using this strategy, a highly potent array of functionalized oxime PolQ inhibitors displaying promising initial ADME properties was delivered, underscoring the power of generative AI to unlock new chemical space and accelerate lead optimization.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Protein-protein Interfaces